Main menu

Value of Medicines

Value of Medicines

A collection of papers demonstrating the impact of medicines on public health and the economy.

Future Topics in Development:

  • Papers will soon be available demonstrating value in a variety of areas including Rare Diseases, Pain, Breast Cancer, and more. Stay tuned!

Pfizer has long maintained that medicines provide tremendous value to individuals and society as a whole. We have now captured that value in a series of concise, easy-to-access papers that detail the societal and economic value provided by medicines that treat various disease areas. The data we provide come from published, peer-reviewed studies and are complemented by real stories from patients who have benefited from medicines. We hope these will serve as a resource to those looking to quantify the value of medicines.

Jack Watters, Vice President of External Medical Affairs, discusses Pfizer’s Value of Medicines campaign with the National Association of Chain Drug Stores (NACDS). Click here to read the full interview.


Select Infographics from these papers:







From Value of Oncology Medicines: 5-Year Relative Survival Rates for Cancers in US2


From Value of Drug Adherence: Return on Investment from Improved Medication Adherence: Diabetes3


History of Development: Targeted Treatment Options for Advanced RCC

Thirty-three percent of all smoking-related deaths are from cardiovascular diseases

Total Cost of Diagnosed Diabetes in the US 2007–2012

Smokers in the USA

World Cigarette Consumption


From Value of Statins: Societal Health Impact1


1 See Value of Statins for multiple references

2 National Cancer Institute, Survival Epidemiology and End Results (SEER), posted to website, viewed at in September, 2013.

3 Adopted from: M. Sokol et al., “Impact of Medication Adherence on Hospitalization Risk and Healthcare Cost,” Journal of Medical Care, 2005. Notes: Adherence is the extent to which patients take medicines as prescribed, in terms of dose and duration. Return on Investment estimates reflect spending attributable to the condition listed.